|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.010 AUD | +1.00% |
|
-4.72% | -6.91% |
| 16/01 | Orthocell Finalizes Agreement With Biotechnology Company | MT |
| 16/01 | Orthocell finalises strategic investment in Marine Biomedica | RE |
EPS & Dividend: Orthocell Limited
| Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.036 | -0.0484 | -0.047 | -0.032 | -0.036 | -0.0384 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 0.315 | 0.590 | 0.405 | 0.350 | 0.355 | 1.175 |
| Nbr of stocks (in thousands) | 1,84,699 | 1,90,584 | 1,97,128 | 1,97,303 | 2,09,327 | 2,43,344 |
| Announcement Date | 31/08/20 | 27/08/21 | 30/08/22 | 31/08/23 | 30/08/24 | 29/08/25 |
1AUD in Million2AUD
Estimates
Upcoming events: Orthocell Limited
| 03/03/2026 | Q2 2026 Earnings Release (Projected) |
| 28/08/2026 | Q4 2026 Earnings Release (Projected) |
| 02/03/2027 | Q2 2027 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 16.37x | |
| 0.27% | 0.28% | 34.68x | 4.46x | 5.89x | |
| -.--% | -.--% | 71.53x | 10.02x | 18.56x | |
| 0.53% | 0.58% | 44.7x | 3.27x | 7.35x | |
| -.--% | -.--% | 43.2x | 5.29x | 6.95x | |
| 2.25% | 2.55% | 22.3x | 2.71x | 2.59x | |
| -.--% | -.--% | 37.19x | 4.58x | 7.54x | |
| 0.74% | 0.78% | 26.35x | 5.09x | 5.53x | |
| 0.94% | 1.03% | 24.52x | 5.49x | 6.48x | |
| 0.17% | 0.19% | 17.83x | 3.54x | 2.06x | |
| Average | 0.54% | 0.6% | 35.81x | 4.94x | 7.93x | |
| Weighted average by Cap. | 0.38% | 0.41% | 42.97x | 5.41x | 8.58x |
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition